Yohimbine is an alkaloid derived from the bark of the Pausinystalia yohimbe tree, traditionally used in West African medicine. As a selective α2-adrenergic receptor antagonist, it uniquely targets stubborn fat areas while enhancing physical performance. This guide examines its science-backed applications and critical safety protocols.
Yohimbine remains one of few supplements with direct α2-adrenergic activity, making it uniquely effective for stubborn fat and certain ED cases. However, its narrow therapeutic window demands:
✅ Medical supervision for doses >5mg ✅ Cardiac monitoring in at-risk users ✅ Strict cycling (max 60 days with 30-day breaks)
*”0.2mg/kg yohimbine + fasted cardio mobilizes 300% more fatty acids from lower abdomen vs cardio alone”* ― Journal of International Society of Sports Nutrition
References
Ostojic SM. (2006). “Yohimbine: Effects on Body Composition”. J Int Soc Sports Nutr.
Ernst E, Pittler MH. (1998). “Yohimbine for Erectile Dysfunction”. Br J Clin Pharmacol.
Galitzky J, et al. (2018). “Alpha-2 Antagonist Pharmacology”. Front Pharmacol.
FDA Safety Alert. (2023). “Adulterated Yohimbe Products”. FDA.gov.
Lebret T, et al. (2002). “Efficacy in ED Treatment”. Eur Urol.